SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-23-001925
Filing Date
2023-01-06
Accepted
2023-01-06 17:57:20
Documents
2
Period of Report
2023-01-05

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm232299-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm232299-1_4seq1.xml 4 5691
2 EXHIBIT 99 tm232299d1_ex99.htm EX-99 104774
  Complete submission text file 0001104659-23-001925.txt   112253
Mailing Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154
Business Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154 781-652-4500
Fortress Biotech, Inc. (Reporting) CIK: 0001429260 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38128 | Film No.: 23516121
SIC: 2834 Pharmaceutical Preparations

Mailing Address 95 SAWYER ROAD SUITE 110 WALTHAM MA 02453
Business Address 95 SAWYER ROAD SUITE 110 WALTHAM MA 02453 781-652-4500
Checkpoint Therapeutics, Inc. (Issuer) CIK: 0001651407 (see all company filings)

IRS No.: 472568632 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations